Checkmate Pharmaceuticals, Inc. (21) | Uncategorized (2)
- Interim CEO Agreement between Checkmate Pharmaceuticals, Inc. and Alan Fuhrman, dated as of October 27, 2021 (Filed With SEC on October 27, 2021)
- Description of Securities (Filed With SEC on March 29, 2021)
